[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100375208":3},{"organization":4,"armGroups":7,"interventions":28,"overallOfficials":34,"centralContacts":39,"locations":44,"responsibleParty":195,"collaborators":34,"id":197,"slug":198,"hasResults":199,"nctId":200,"briefTitle":201,"officialTitle":202,"acronym":203,"eligibilityCriteria":204,"healthyVolunteers":199,"sex":205,"minAge":206,"maxAge":207,"enrollmentInfo":208,"targetDuration":34,"studyType":211,"phases":212,"briefSummary":214,"conditions":215,"keywords":34,"overallStatus":47,"whyStopped":34,"lastUpdateSubmitDate":217,"lastUpdatePostDateStruct":218,"startDateStruct":221,"completionDateStruct":223,"leadSponsor":225,"locationsCount":226},{"fullName":5,"class":6},"Ionis Pharmaceuticals, Inc.","INDUSTRY",[8,14,20,24],{"label":9,"type":10,"description":11,"interventionNames":12},"Part 1: ION464","EXPERIMENTAL","ION464 will be administered at multiple-ascending doses by IT injection at regular intervals over 12 weeks.",[13],"Drug: ION464",{"label":15,"type":16,"description":17,"interventionNames":18},"Part 1: Placebo","PLACEBO_COMPARATOR","ION464-matching placebo will be administered by IT injection at regular intervals over 12 weeks.",[19],"Drug: Placebo",{"label":21,"type":10,"description":22,"interventionNames":23},"Part 2: ION464","ION464 will be administered at the same doses as Part 1 by IT injection, at regular intervals, for 72 weeks.",[13],{"label":25,"type":16,"description":26,"interventionNames":27},"Part 2: Placebo","ION464-matching placebo will be administered by IT injection, at regular intervals, for 72 weeks.",[19],[29,35],{"type":30,"name":31,"description":32,"armGroupLabels":33,"otherNames":34},"DRUG","ION464","ION464 will be administered by IT injection.",[9,21],null,{"type":30,"name":36,"description":37,"armGroupLabels":38,"otherNames":34},"Placebo","ION464-matching placebo will be administered by IT injection.",[15,25],[40],{"name":5,"role":41,"phone":42,"phoneExt":34,"email":43},"CONTACT","(844) 748-5844","IonisHORIZONStudy@clinicaltrialmedia.com",[45,58,69,78,87,99,108,117,127,136,145,156,168,177,186],{"facility":46,"status":47,"city":48,"state":34,"zip":49,"country":50,"countryCode":51,"cosmosGeoPoint":52,"geoPoint":57,"contacts":34},"Medizinische Universität Innsbruck","RECRUITING","Innsbruck","6020","Austria","AT",{"type":53,"coordinates":54},"Point",[55,56],11.39454,47.26266,{"lat":56,"lon":55},{"facility":59,"status":47,"city":60,"state":34,"zip":61,"country":62,"countryCode":63,"cosmosGeoPoint":64,"geoPoint":68,"contacts":34},"CHU de Lyon - Hospices Civils de Lyon-H6pital Pierre Wertheimer, Neurologique HCL","Lyon","69500","France","FR",{"type":53,"coordinates":65},[66,67],4.84789,45.74906,{"lat":67,"lon":66},{"facility":70,"status":47,"city":71,"state":34,"zip":72,"country":62,"countryCode":63,"cosmosGeoPoint":73,"geoPoint":77,"contacts":34},"Groupe Hospitalier Pitie-Salpetriere","Paris","75013",{"type":53,"coordinates":74},[75,76],2.3488,48.85341,{"lat":76,"lon":75},{"facility":79,"status":47,"city":80,"state":34,"zip":81,"country":62,"countryCode":63,"cosmosGeoPoint":82,"geoPoint":86,"contacts":34},"Hopital Purpan","Toulouse","31059",{"type":53,"coordinates":83},[84,85],1.44367,43.60426,{"lat":85,"lon":84},{"facility":88,"status":47,"city":89,"state":90,"zip":91,"country":92,"countryCode":93,"cosmosGeoPoint":94,"geoPoint":98,"contacts":34},"Universitaetsklinikum Ulm","Ulm","Baden-Wurttemberg","89081","Germany","DE",{"type":53,"coordinates":95},[96,97],9.99155,48.39841,{"lat":97,"lon":96},{"facility":100,"status":47,"city":101,"state":34,"zip":102,"country":92,"countryCode":93,"cosmosGeoPoint":103,"geoPoint":107,"contacts":34},"Universitaetsklinikum Duesseldorf AoeR","Düsseldorf","40225",{"type":53,"coordinates":104},[105,106],6.77927,51.22319,{"lat":106,"lon":105},{"facility":109,"status":47,"city":110,"state":34,"zip":111,"country":92,"countryCode":93,"cosmosGeoPoint":112,"geoPoint":116,"contacts":34},"University Medical Center Göttingen, Clinic for Neurology","Göttingen","37075",{"type":53,"coordinates":113},[114,115],9.93228,51.53443,{"lat":115,"lon":114},{"facility":118,"status":119,"city":120,"state":34,"zip":121,"country":92,"countryCode":93,"cosmosGeoPoint":122,"geoPoint":126,"contacts":34},"Medizinische Hochschule Hannover (MHH)","COMPLETED","Hanover","30625",{"type":53,"coordinates":123},[124,125],9.73322,52.37052,{"lat":125,"lon":124},{"facility":128,"status":47,"city":129,"state":34,"zip":130,"country":92,"countryCode":93,"cosmosGeoPoint":131,"geoPoint":135,"contacts":34},"University Hospital Marburg","Marburg","35043",{"type":53,"coordinates":132},[133,134],8.77069,50.80904,{"lat":134,"lon":133},{"facility":137,"status":47,"city":138,"state":34,"zip":139,"country":92,"countryCode":93,"cosmosGeoPoint":140,"geoPoint":144,"contacts":34},"Klinikum der Universtiatet Muenchen -Campus Grosshadern","München","81377",{"type":53,"coordinates":141},[142,143],13.31243,51.60698,{"lat":143,"lon":142},{"facility":146,"status":47,"city":147,"state":34,"zip":148,"country":149,"countryCode":150,"cosmosGeoPoint":151,"geoPoint":155,"contacts":34},"Hospital Beatriz Ângelo","Loures","2674-514","Portugal","PT",{"type":53,"coordinates":152},[153,154],-9.16845,38.83091,{"lat":154,"lon":153},{"facility":157,"status":47,"city":158,"state":159,"zip":160,"country":161,"countryCode":162,"cosmosGeoPoint":163,"geoPoint":167,"contacts":34},"Institute of Neurology & The National Hospital for Neurology and Neurosurgery","London","England","WC1N 3BG","United Kingdom","UK",{"type":53,"coordinates":164},[165,166],-0.12574,51.50853,{"lat":166,"lon":165},{"facility":169,"status":47,"city":170,"state":159,"zip":171,"country":161,"countryCode":162,"cosmosGeoPoint":172,"geoPoint":176,"contacts":34},"The John Radcliffe Hospital","Oxford","OX3 9DU",{"type":53,"coordinates":173},[174,175],-1.25596,51.75222,{"lat":175,"lon":174},{"facility":178,"status":47,"city":179,"state":34,"zip":180,"country":161,"countryCode":162,"cosmosGeoPoint":181,"geoPoint":185,"contacts":34},"Salford Royal Hospital","Salford","M6 8HD",{"type":53,"coordinates":182},[183,184],-2.29042,53.48771,{"lat":184,"lon":183},{"facility":187,"status":47,"city":188,"state":34,"zip":189,"country":161,"countryCode":162,"cosmosGeoPoint":190,"geoPoint":194,"contacts":34},"Southampton General Hospital","Southampton","SO16 6YD",{"type":53,"coordinates":191},[192,193],-1.40428,50.90395,{"lat":193,"lon":192},{"type":196,"investigatorFullName":34,"investigatorTitle":34,"investigatorAffiliation":34,"oldNameTitle":34,"oldOrganization":34},"SPONSOR","100375208","phase-1-study-to-evaluate-the-safety-tolerability-and-pharmacokinetics-of-ion464-administered-to-adults-with-multiple-system-atrophy-horizon-100375208",false,"NCT04165486","Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ION464 Administered to Adults With Multiple System Atrophy (HORIZON)","A Phase 1 Study to Assess the Safety, Tolerability, and Pharmacokinetics of ION464 Administered Intrathecally to Adults With Multiple System Atrophy","HORIZON","Key Inclusion Criteria:\n\n* Screening single-photon emission computed tomography (SPECT) with DaTscan™ (ioflupane I123 injection) results demonstrating loss (whether symmetric or asymmetric) of dopamine nerve terminals in the striatum consistent with neurodegenerative parkinsonism, as assessed with qualitative, visual read.\n* Diagnosed with probable or possible MSA, either parkinsonian-type (MSA-P) or cerebellar-type (MSA-C).\n* Must be able to walk unassisted for at least 10 meters (approximately 30 feet)\n\nKey Exclusion Criteria:\n\n* Presence of cognitive dysfunction (defined as Montreal Cognitive Assessment (MoCA) score \\\u003C25)\n* Family history of ataxia or parkinsonism and known genetic cause of ataxia or parkinsonism.\n\nNOTE: Other protocol defined Inclusion\u002F Exclusion criteria may apply.","ALL","40 Years","70 Years",{"count":209,"type":210},40,"ESTIMATED","INTERVENTIONAL",[213],"PHASE1","The primary objectives are to evaluate the safety and tolerability of multiple doses of ION464 administered via intrathecal (IT) injection (Part 1) and to evaluate the long-term safety and tolerability of ION464 (Part 2) in participants with multiple system atrophy (MSA).\n\nThe secondary objectives are to evaluate the pharmacodynamic (PD) effect of ION464 on the level of a potential biomarker of target engagement (Parts 1 and 2) and to evaluate the pharmacokinetic (PK) profile of ION464 in serum (Part 1).",[216],"Multiple System Atrophy","2026-04-24",{"date":219,"type":220},"2026-04-27","ACTUAL",{"date":222,"type":220},"2022-07-21",{"date":224,"type":210},"2027-09",{"name":5,"class":6},15]